Method - therapeutic
- Therapeutic Approaches to Inflammatory Joint Diseases by Inhibition of the NURR Subfamily of Nuclear Transcription Factors - 00-053
- Targeting Stat3 with G-Quartet Oligodeoxynucleotides in Human Cancer Cells - Improved Intracellular Delivery - Inhibition of Stat3 Dimerization - 01-074
- P38MAPK as a Marker for Predicting Tamoxifen Resistance - 01-105
- Immune Complex Vaccination: Overcoming Age-Associated Immunodeficiency - 04-002
- Detergent-Mediated Phospholipidation of Total Plasma Lipoproteins: A simple, robust method to augment Reverse Cholesterol Transport - 04-128
- An oncolytic virus derived from HSV-2 that can effectively and selectively lyse tumor cells - 05-099
- Master Regulators of Hematopoietic Differentiation: Defining the Transcriptome of the Hematopoietic System. - 06-066
- Silencing of the Zinc Transporter ZIP4 Inhibits Pancreatic Cancer Growth and Augments Survival in Pancreatic Cancer Xenograft Models. - 08-037
- Dorsal Root Ganglion Targeting Peptides - 08-045
- Ronin: An Essential Factor for Embryonic Stem Cell Potency and Renewal - 08-067
- Suppression of NLRC5 Expression as an Immunotherapeutic Target: "Releasing the Brake" on an Important Negative Regulator of NF-kappaB and Type-I Interferon Responses. - 10-020